Ligand validation:6ZO6

LPX: (2S)-3-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl hexadecanoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZO6_LPX_C_1119	18%	89%	0.262	0.853	0.28	0.37	-	-	0	0	100%	1
7OUK_LPX_C_1707	25%	89%	0.275	0.91	0.29	0.35	-	-	0	0	100%	1
6ZO5_LPX_C_1101	22%	88%	0.239	0.857	0.3	0.36	-	-	0	0	100%	1
6ZOH_LPX_C_1106	18%	89%	0.268	0.853	0.29	0.36	-	-	0	0	100%	1
6ZO8_LPX_C_1123	14%	89%	0.254	0.804	0.3	0.35	-	-	0	0	100%	1
7OUL_LPX_C_1602	6%	89%	0.395	0.825	0.29	0.35	-	-	0	0	100%	1
3CX9_LPX_A_2001	22%	52%	0.245	0.864	0.86	0.99	1	2	22	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.